BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
cCAM Biotherapeutics is defunct.

Fate: Acquired by Merck, Aug 2015, $605M


------------------
If you believe any of this information is incorrect, please let us know.